AmeriCann, Inc.

Equities

ACAN

US0305881072

Healthcare Facilities & Services

Market Closed - OTC Markets Other stock markets 10:09:38 2024-04-24 am EDT			5-day change	1st Jan Change
0.061 ^USD	-6.15%		-10.29%	-28.24%

Feb. 14	AmeriCann, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	CI
2023	AmeriCann, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023	CI

AMERICANN, INC. : Other Events, Financial Statements and Exhibits (form 8-K)

January 09, 2023 at 11:20 am EST

Item 8.01 Other Events

On January 9th, 2023 the Company issued a Press Release concerning year-end and quarterly revenue for the period ending September 30, 2022 and an update on the operations of its Massachusetts Cannabis Center.

A copy of the Press Release is filed as Exhibit 99 to this report.

Item 9.01 Financial Statements and Exhibits

Number Description

99 January 9th, 2023, Press Release

104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

--------------------------------------------------------------------------------

Latest news about AmeriCann, Inc.

AmeriCann, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	Feb. 14	CI
AmeriCann, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023	Dec. 22	CI
Americann, Inc. Announces Loan Modification Agreement	Dec. 11	CI
AmeriCann, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	23-08-14	CI
AmeriCann, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	23-05-11	CI
Earnings Flash (ACAN) AMERICANN Posts Q4 Revenue $734.8M	23-02-16	MT
Earnings Flash (ACAN) AMERICANN Posts Q4 Revenue $734,764	23-02-16	MT
AmeriCann, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2022	23-02-14	CI
AmeriCann, Inc. Reports Earnings Results for the Full Year Ended September 30, 2022	22-12-29	CI
AmeriCann, Inc. Auditor Raises 'Going Concern' Doubt	22-12-28	CI
Americann, Inc. Reports Sales Results for the Period Ended September 2022	22-10-19	CI
AmeriCann, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022	22-08-15	CI
AmeriCann, Inc. Reports Sales Results for the Month and Quarter Ended June 2022	22-07-12	CI
AmeriCann, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2022	22-05-16	CI
AmeriCann, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2021	22-02-14	CI
AmeriCann, Inc. Reports Earnings Results for the Full Year Ended September 30, 2021	21-12-06	CI
AmeriCann, Inc. Auditor Raises 'Going Concern' Doubt	21-12-05	CI
Americann, Inc. Reports Earnings Results for the Third Quarter Ended June 30, 2021	21-08-16	CI
Americann, Inc. Reports Earnings Results for the Second Quarter Ended March 31, 2021	21-05-13	CI
Americann, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2020	21-02-16	CI
Americann Launches Respected Cannabis Products Out of AmeriCann's Development, the Massachusetts Cannabis Center	21-02-11	CI
Americann, Inc. Reports Earnings Results for the Full Year Ended September 30, 2020	20-12-21	CI
AmeriCann, Inc. Auditor Raises 'Going Concern' Doubt	20-12-20	CI
AmeriCann Received Two Licenses from the Massachusetts Cannabis Control Commission	20-11-20	CI
AmeriCann, Inc. Benefits from Increased Production/Sales at its Massachusetts Cannabis Center	20-10-06	CI

Chart AmeriCann, Inc.

Duration

Period

More charts

Company Profile

AmeriCann, Inc. is a cannabis company that develops cultivation, processing and product manufacturing facilities. It has provisional licenses to produce cannabis-infused products, including beverages, edibles, topicals and concentrates. It designs GMP-certified cannabis extraction and product manufacturing infrastructure. Its flagship project is the Massachusetts Cannabis Center (MCC), which is being developed on a 52-acre parcel. MCC project is permitted for over 800,000 square feet of cannabis cultivation and processing infrastructure which is being developed in phases to support both the existing medical cannabis and the emerging adult-use cannabis marketplace. The Company, through a 100% owned subsidiary, AmeriCann Brands, Inc., has received two licenses from the Massachusetts Cannabis Control Commission to cultivate cannabis and provide extraction and product manufacturing support to the entire MCC project, as well as to other licensed cannabis farmers throughout regulated market.

Sector

Healthcare Facilities & Services

More about the company

Income Statement Evolution

More financial data

Sector Medical Farming

	1st Jan change	Capi.
AMERICANN, INC.	-28.24%	1.49M
ASCEND WELLNESS HOLDINGS, INC.	+31.96%	272M
AYR WELLNESS INC.	+38.27%	269M
ORGANIGRAM HOLDINGS INC.	+54.65%	200M
JUSHI HOLDINGS INC.	+48.33%	134M
THE CANNABIST COMPANY HOLDINGS INC.	-39.97%	124M
IANTHUS CAPITAL HOLDINGS, INC.	-28.57%	121M
INTERCURE LTD.	+115.91%	120M
BAKHU HOLDINGS, CORP.	+150.00%	75.33M
4FRONT VENTURES CORP.	-23.08%	66.62M

Medical Farming